Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients.

Biotechnology

Achaogen

Noe Reyes

shuang wu

Achaogen's CEO and Executive Team includes Blake Wise.

CEO and Executive Team

About

Other teams at Achaogen

Leadership Team